Details of the Optogenetic System
| General Information of This Optogenetic System (OS) | ||||||
|---|---|---|---|---|---|---|
| OS ID |
OS00029
|
|||||
| OS Name |
Light inducible nuclear translocation and dimerization system
(LINTAD)
|
[1] | ||||
|
Photoreceptor (PR) |
|
|||||
| Complementary Protein | Cryptochrome-interacting basic-helix-loop-helix 1 (CIB1/CIBN) | |||||
| Cofactor | Flavin adenine dinucleotide (FAD) | |||||
| Controlled Protein | Fusion protein | LexA activation domain | ||||
| Recruited protein | Transcription regulator LexA | |||||
| OS Application Information (1) | ||||||
|---|---|---|---|---|---|---|
| Mechanism of Action | CRY2-CIB1 heterodimerization | [ 1] | ||||
| Controlled Signal Pathway | Gene expression activation | |||||
| Effect | Activation | |||||
| Application | Control transcription in CAR T cell for cancer therapy | |||||
| Note | LexA-VP is an orthogonal transcription factor | |||||
| Light Information | Activation Wavelength | 460 nm | ||||
| Process | Reversible | |||||
| Deactivation Wavelength | Dark | |||||
| Activation Time | Seconds | |||||
| Deactivation Time | Minutes | |||||
| Light Intensity | 5 milliwatts per square centimeter | |||||
| Expression Information | Expression Method | Transduction and Transfection | ||||
| Cell Lines | CAR T cells | |||||